The Jefferies Group LLC Reiterates Buy Rating for Express Scripts Holding Company (ESRX)

The Jefferies Group LLC Reiterates Buy Rating for Express Scripts Holding Company (ESRX)

Express Scripts Holding Company (NASDAQ:ESRX)‘s stock had its “buy” rating reissued by research analysts at Jefferies Group LLC in a report issued on Thursday. Jefferies Group also issued estimates for Express Scripts Holding’s FY2017 earnings at $7.02 EPS and FY2018 earnings at $7.60 EPS.

A number of other equities analysts have also recently issued reports on ESRX. Royal Bank Of Canada set a $66.00 price objective on Express Scripts Holding and gave the company a “hold” rating in a report on Wednesday. Robert W. Baird boosted their price objective on Express Scripts Holding from $57.00 to $59.00 and gave the company a “neutral” rating in a report on Wednesday. Zacks Investment Research cut Express Scripts Holding from a “buy” rating to a “sell” rating in a report on Tuesday. BidaskClub cut Express Scripts Holding from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Finally, Mizuho set a $67.00 price objective on Express Scripts Holding and gave the company a “hold” rating in a report on Tuesday. Seven investment analysts have rated the stock with a sell rating, eleven have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Express Scripts Holding currently has an average rating of “Hold” and a consensus target price of $69.56.

Shares of Express Scripts Holding (NASDAQ:ESRX) traded up 0.88% during trading on Thursday, hitting $61.70. The company had a trading volume of 2,688,530 shares. The stock’s 50-day moving average price is $61.18 and its 200 day moving average price is $62.00. The company has a market capitalization of $35.63 billion, a P/E ratio of 10.71 and a beta of 0.88. Express Scripts Holding has a 52 week low of $55.80 and a 52 week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the previous year, the business earned $1.74 EPS. Express Scripts Holding’s revenue was down 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Express Scripts Holding will post $7.00 earnings per share for the current year.

In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now directly owns 11,500 shares of the company’s stock, valued at approximately $735,195. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Everett Neville sold 1,163 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the transaction, the vice president now directly owns 18,232 shares in the company, valued at $1,120,903.36. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,641 shares of company stock valued at $357,317. Corporate insiders own 0.68% of the company’s stock.

A number of large investors have recently made changes to their positions in ESRX. Waldron LP acquired a new position in Express Scripts Holding during the 1st quarter valued at about $206,000. 1st Global Advisors Inc. increased its position in Express Scripts Holding by 22.9% during the 1st quarter. 1st Global Advisors Inc. now owns 9,963 shares of the company’s stock valued at $657,000 after buying an additional 1,855 shares in the last quarter. Shufro Rose & Co. LLC increased its position in Express Scripts Holding by 43.1% during the 1st quarter. Shufro Rose & Co. LLC now owns 22,374 shares of the company’s stock valued at $1,475,000 after buying an additional 6,741 shares in the last quarter. Hancock Holding Co. increased its position in Express Scripts Holding by 9.9% during the 1st quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock valued at $12,094,000 after buying an additional 16,536 shares in the last quarter. Finally, Pacer Advisors Inc. increased its position in Express Scripts Holding by 13.3% during the 1st quarter. Pacer Advisors Inc. now owns 25,459 shares of the company’s stock valued at $1,678,000 after buying an additional 2,985 shares in the last quarter. 88.67% of the stock is currently owned by institutional investors.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Related posts

Leave a Comment